Risk models for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP): Smoking and chronic liver disease are predictors of protection against PEP

Pancreas

Volumn 42, Issue 6, 2013, Pages 996-1003

  Dimagno, Matthew J ^a   Spaete, Joshua P ^a   Ballard, Darren D ^a   Wamsteker, Erik Jan ^a   Saini, Sameer D ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

9th edition; AIDS acquired immune deficiency syndrome; BMI body mass index; CI confidence interval; CLD chronic liver disease; CVD cardiovascular disease; ERCP endoscopic retrograde cholangiopancreatography; ICD 9 International Classification of Diseases; IDX information data exchange; MDC moderate difficult cannulation; OR odds ratio; PEP; PEP post ERCP pancreatitis; SOD sphincter of Oddi

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CHARLSON COMORBIDITY INDEX; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PRIORITY JOURNAL; PROTECTION; SMOKING; SPHINCTEROTOMY; SYSTEMATIC REVIEW (TOPIC); VATER PAPILLA STENOSIS;

ADULT; CASE-CONTROL STUDIES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHRONIC DISEASE; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 84880696916     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31827e95e9     Document Type: Article

References (35)

1. Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781-1788.
2. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54(4):425-434.
3. Friedland S, Soetikno RM, Vandervoort J, et al. Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy. 2002;34(6):483-488.
4. Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73(2):275-282.
5. Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57(9):1262-1267.
6. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366(15):1414-1422.
7. Feurer ME, Adler DG. Post-ERCP pancreatitis: review of current preventive strategies. Curr Opin Gastroenterol. 2012;28(3):280-286.
8. Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101(1):139-147.
9. Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy. 2007;39(9):793-801.
10. Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009;104(1):31-40.
11. Debenedet AT, Raghunathan TE, Wing JJ, et al. Alcohol use and cigarette smoking as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2009;7(3):353e354-358e354.
12. Stumpf HH. Microatheromas of very small arteries: unusual lesions involving primarily the pancreas. Hum Pathol. 1983;14(12):1039-1043.
13. Pollak OJ. Human pancreatic atherosclerosis. Ann N Y Acad Sci. 1968;149(2):928-939.
14. Klar E, Messmer K, Warshaw AL, et al. Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg. 1990;77(11):1205-1210.
15. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383-393.
16. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
17. Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83(1):356-362.
18. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646-649.
19. Geenen JE, Hogan WJ, Dodds WJ, et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med. 1989;320(2):82-87.
20. Kozarek RA. Biliary dyskinesiaVare we any closer to defining the entity? Gastrointest Endosc Clin North Am. 1993;3:167-178.
21. Li N, Tieng A, Novak S, et al. Effects of medications on post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreatology. 2010;10(2-3):238-242.
22. Tolstrup JS, Kristiansen L, Becker U, et al. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. Arch Intern Med. 2009;169(6):603-609.
23. Lindkvist B, Appelros S, Manjer J, et al. A prospective cohort study of smoking in acute pancreatitis. Pancreatology. 2008;8(1):63-70.
24. Sadr-Azodi O, Andren-Sandberg A, Orsini N, et al. Cigarette smoking, smoking cessation and acute pancreatitis: a prospective population-based study. Gut. 2012;61(2):262-267.
25. Wittel UA, Pandey KK, Andrianifahanana M, et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol. 2006;101(1):148-159.
26. Jianyu H, Guang L, Baosen P. Evidence for cigarette smoke-induced oxidative stress in the rat pancreas. Inhal Toxicol. 2009;21(12):1007-1012.
27. Hartwig W, Werner J, Ryschich E, et al. Cigarette smoke enhances ethanol-induced pancreatic injury. Pancreas. 2000;21(3):272-278.
28. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117(2):289-296.
29. van Westerloo DJ, Giebelen IA, Florquin S, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology. 2006;130(6):1822-1830.
30. McGrath J, McDonald JW, Macdonald JK. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2004;(4):CD004722.
31. Bagcivan I, Kaya T, Turan M, et al. Investigation of the mechanism of nicotine-induced relaxation on the sheep sphincter of Oddi. Can J Physiol Pharmacol. 2004;82(11):935-939.
32. DiMagno MJ, Shah A, Tesmer T, et al. Cigarette smoke extract (CSE) but not nicotine enhances secretagogue evoked pancreatic acinar necrosis. Pancreas. 2010;39(8):A1318.
33. Little RJA, Rubin DB. Statistical Analysis With Missing Data. 2nd ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2002.
34. Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086-1093.
35. Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2007;5(11):1354-1365.